Hopital De La Croix-Rousse — Clinical Trial Site

69 Registered trials

24 Currently recruiting

Organisation

Hopital De La Croix-Rousse

Location

Lyon Cedex 04, France

Identifier

ORG-100028712

Address

103 Grande Rue De La Croix Rousse, 69317, France

Departments

1802: Gastroenterology
250003: Ophtalmologie
anesthésie-réanimation
Cardiology
chirugie Digestive et Générale
Dermatology
Gastro enterology
Gastroenterology
Gynecology - Obstetrics
hépato gastro enterology
Hépato Gastroentérologie
Hepato-gastro-enterology department
Hépato-gastroentérologie
Hépato-gastroentérologue oncologue
Hepato-gastroenterology
Hepato-Gastroenterology Department
Hepatogastro enterology
Hepatology
Hepatology and Gastroenterology
Hepatology and gastroenterology department
Hopital de la croix rousse; Ophtalmologie
Hospital de Lyon Nord – Croix Rousse
Infectiologie
Infectious and tropical diseases
Infectious diseas
Infectious disease
Infectious Diseases
Internal Medecine
Médecine Intensive et Réanimation
Médecine Interne
Medical oncology
Oncologie
Oncologie médicale
Oncology
Ophtalmologie
Ophtalmology
Ophthalmology
ORL et Chirurgie Cervico-faciale
Pneumologie
Pneumology
Service d'Hépato Gastro Entérologie
Service d'Hépato-Gastro-Entérologie
Service d'hépatologie et gastroentérologie
Service d'oncologie médicale
Service d'ophtalmologie
Service d'Ophtalomologie
Service d’ophtalmologie
Service de Pneumologie
Service Hépato-Gastroenterologie
Service pneumologie
site 008_Service Maladies infectieuses et tropicales

Clinical trials at this site (69)

Search interface

A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised

2022-502126-40-00 HIV-1 infection 5
A clinical study of people with HIV-1 who take antiretroviral therapy and switch their treatment to a combination of doravirine and islatrav… Not authorised

2022-502127-22-00 HIV-1 Infection 5
BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis Pending

2024-516849-39-01 antibiotic therapy in Sepsis 5
Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter ran… Pending

2024-518018-22-00 staphylococcal endocarditis 5
Evaluating a Personalized Treatment Strategy for Young Women with Early Breast Cancer Pending

2024-519655-28-00 Premenopausal patients with high-risk HR-positive/HER2- 5
ENGIC 02 - PRODIGE 86-FOLFIRINOX SBA- Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanc… Recruiting

2023-505486-92-00 Small bowel adenocarcinoma 4 2024-02-09
A Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors Recruiting

2023-510275-64-00 Hepatocellular carcinoma, colorectal cancer, endometria 9 2023-05-31
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-02) Recruiting

2025-522873-12-00 ER+, HER2- Advanced Breast Cancer 5 2026-02-24
Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection via Hysteroscopy in Severe Primary Dysmenorrhea: A Prospecti… Recruiting

2025-520638-53-00 Severe primary dysmenorrhea 5 2026-02-09
Safety of Atezolizumab/Bevacizumab in liver transplanted patients with advanced hepatocellular carcinoma (IMMUNO-TH) Recruiting

2024-514400-14-00 liver transplanted patients with advanced hepatocellula 4 2026-01-23
A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advan… Recruiting

2025-520566-22-00 Hormone Receptor-Positive, HER2-Negative Advanced/Metas 5 2025-11-10
metastatic colorectal cancer Recruiting

2023-504831-42-00 patient with colorectal cancer with hepatic metastasis 5 2025-06-27
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmona… Recruiting

2024-517457-27-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2025-06-04
Dose Range Finding Study to Access Efficacy and Safety of Tozorakimab in Adults with Uncontrolled Asthma on Medium-to-High Dose Inhaled Cort… Recruiting

2024-519116-14-00 Asthma 4 2025-05-27
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2025-05-22
A trial to learn how well benralizumab works and how safe it is when given in addition to standard asthma treatments in people with eosinoph… Recruiting

2024-515162-13-00 Eosinophilic Asthma 5 2025-04-29
Evaluation of the benefits of Administering immunosuppressive drugs as Single daily doses over the first Year after liver transplantation Recruiting

2023-506601-19-00 transplantation 6 2025-04-15
Clinical trial of patritumab deruxtecan in people with gastrointestinal cancers Recruiting

2024-512442-41-00 Colorectal Carcinoma, Biliary Tract Carcinoma, Hepatoce 9 2024-12-03
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensate… Recruiting

2024-512895-36-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5 2024-11-25
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides difficile Infection: The Re… Recruiting

2022-502972-22-00 Clostridioides difficile infection. 5 2024-10-31
Linezolid or vancomycin surgical site infection prophylaxis LOVip Recruiting

2023-504986-22-00 surgical antibiotic prophylaxis 5 2024-09-30
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
Study to learn about the safety of fazirsiran and if it can help people with alpha-1 antitrypsin liver disease with mild liver scarring (fib… Recruiting

2023-504198-19-00 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 5 2024-04-18
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Cirrho… Recruiting

2023-505141-48-00 Fibrosis 5 2024-03-07